Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Myeloid 1Lymphoid 1Head & Neck 1Genitourinary 1CNS 1Breast 1

Conditions

Breast Neoplasms 3137Triple Negative Breast Neoplasms 514Ovarian Neoplasms 230Colorectal Neoplasms 190Carcinoma, Non-Small-Cell Lung 189Prostatic Neoplasms 184Neoplasms 176Neoplasm Metastasis 164Lung Neoplasms 164Melanoma 118Stomach Neoplasms 114Pancreatic Neoplasms 113Endometrial Neoplasms 107Uterine Cervical Neoplasms 95Squamous Cell Carcinoma of Head and Neck 88Colonic Neoplasms 82Carcinoma, Intraductal, Noninfiltrating 82Head and Neck Neoplasms 81Sarcoma 62Breast Carcinoma In Situ 62Carcinoma, Renal Cell 61Urinary Bladder Neoplasms 60Motor Activity 59Esophageal Neoplasms 58Brain Neoplasms 50Lymphedema 44Breast Cancer Female 41Liver Neoplasms 39Advanced Breast Cancer 39HER2-positive Breast Cancer 38

Interventions

temsirolimus 1Valproic Acid 1Sirolimus 1Immunoglobulin G 1Disulfides 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphangioleiomyomatosis × Breast × 1 year × Clear all
NCT01552434 2026-05-15

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

M.D. Anderson Cancer Center

Phase 1 Terminated
154 enrolled
BreastCNSGenitourinaryHead & NeckLymphoidMyeloidSarcoma

Breast Neoplasms, Carcinoma, Transitional Cell, Endocrine Gland Neoplasms, Castleman Disease, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms, Pharyngeal Neoplasms, Recurrence, Sarcoma, Soft Tissue Neoplasms, Thyroid Neoplasms, Urologic Neoplasms, Neurofibromatosis 2, Lymphangioleiomyomatosis, Neoplasms, Mesothelial, Erdheim-Chester Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡